Insider Trading activities of Sangamo Biosciences Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sangamo Biosciences Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sangamo Biosciences Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Sangamo Biosciences Inc since 2005. The reporting company's ticker symbol is SGMO. The reporting company's CIK number is 1001233.
The total value of stock buying since 2005 is $56,766,011.
The total value of stock sales since 2005 is $143,229,240.
The total value of stock option exercises since 2005 is $11,527,295.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Sangamo Biosciences Inc insiders (SGMO) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-10-21 Cleveland Paul B (Director) Option Ex 10,000 4.54 45,400
2013-10-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 11.32 283,075
2013-10-10 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 11.28 112,760
2013-10-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2013-10-01 Gregory Philip D (Vice President, Research & CSO) Sale 15,000 10.54 158,085
2013-10-01 Gregory Philip D (Vice President, Research & CSO) Option Ex 15,000 4.32 64,800
2013-09-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 10.57 158,520
2013-09-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 4.08 61,245
2013-09-16 Lanphier Edward O Ii (President & CEO) Sale 25,000 11.29 282,125
2013-09-10 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 10.86 108,590
2013-09-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2013-09-03 Cleveland Paul B (Director) Sale 7,278 10.30 74,977
2013-09-03 Cleveland Paul B (Director) Option Ex 7,278 2.04 14,847
2013-09-03 Gregory Philip D (Vice President, Research & CSO) Sale 15,000 10.33 154,980
2013-09-03 Gregory Philip D (Vice President, Research & CSO) Option Ex 15,000 4.32 64,800
2013-08-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 10.04 150,585
2013-08-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 13,000 4.08 53,079
2013-08-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 10.12 252,875
2013-08-13 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 10.00 100,000
2013-08-13 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2013-08-01 Gregory Philip D (Vice President, Research & CSO) Sale 15,000 9.89 148,320
2013-08-01 Gregory Philip D (Vice President, Research & CSO) Option Ex 15,000 4.32 64,800
2013-07-29 Gregory Philip D (Vice President, Research & CSO) Sale 15,000 10.04 150,570
2013-07-29 Gregory Philip D (Vice President, Research & CSO) Option Ex 15,000 4.52 67,800
2013-07-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 10.11 151,575
2013-07-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 13,000 4.08 53,079
2013-07-25 Kolchinsky Peter Sale 368,870 9.78 3,609,024
2013-07-23 Kolchinsky Peter Sale 5,012 9.37 46,937
2013-07-22 Kolchinsky Peter Sale 111,363 9.57 1,066,300
2013-07-19 Kolchinsky Peter Sale 209,894 9.83 2,063,467
2013-07-18 Kolchinsky Peter Sale 74,035 10.02 741,534
2013-07-17 Kolchinsky Peter Buy 19,200 9.79 187,891
2013-07-17 Kolchinsky Peter Sale 48,270 10.22 493,512
2013-07-17 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 10.00 100,000
2013-07-17 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2013-07-17 Lanphier Edward O Ii (President & CEO) Sale 25,000 10.00 250,000
2013-07-15 Cleveland Paul B (Director) Sale 8,000 9.59 76,720
2013-07-15 Cleveland Paul B (Director) Option Ex 8,000 2.04 16,320
2013-06-03 Gregory Philip D (Vice President, Research & CSO) Sale 3,000 7.88 23,640
2013-06-03 Gregory Philip D (Vice President, Research & CSO) Option Ex 3,000 3.45 10,350
2013-05-28 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 8.32 124,815
2013-05-28 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.61 54,150
2013-05-07 Larson John William (Director) Option Ex 10,000 2.45 24,500
2013-05-01 Gregory Philip D (Vice President, Research & CSO) Sale 6,000 10.09 60,558
2013-05-01 Gregory Philip D (Vice President, Research & CSO) Option Ex 6,000 3.45 20,700
2013-04-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 10.72 160,740
2013-04-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.61 54,150
2013-04-16 Lanphier Edward O Ii (President & CEO) Sale 190 10.00 1,900
2013-04-15 Lanphier Edward O Ii (President & CEO) Sale 5,000 10.00 50,000
2013-04-10 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 10.00 100,000
2013-04-01 Gregory Philip D (Vice President, Research & CSO) Sale 6,000 9.54 57,239
2013-04-01 Gregory Philip D (Vice President, Research & CSO) Option Ex 6,000 3.45 20,700
2013-03-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 9.18 137,730
2013-03-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.61 54,150
2013-03-01 Gregory Philip D (Vice President, Research & CSO) Sale 6,000 10.00 60,006
2013-03-01 Gregory Philip D (Vice President, Research & CSO) Option Ex 6,000 4.92 29,520
2013-02-28 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 10.00 100,000
2013-02-28 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2013-02-28 Lanphier Edward O Ii (President & CEO) Sale 25,000 10.00 250,000
2013-02-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 8.64 129,600
2013-02-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.61 54,150
2013-02-01 Gregory Philip D (Vice President, Research & CSO) Sale 6,000 9.53 57,198
2013-02-01 Gregory Philip D (Vice President, Research & CSO) Option Ex 6,000 4.92 29,520
2013-01-24 Lanphier Edward O Ii (President & CEO) Sale 300 10.00 3,000
2013-01-23 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 10.00 100,000
2013-01-23 Lanphier Edward O Ii (President & CEO) Sale 8,300 10.00 83,008
2013-01-02 Gregory Philip D (Vice President, Research & CSO) Sale 6,000 6.05 36,300
2013-01-02 Gregory Philip D (Vice President, Research & CSO) Option Ex 6,000 4.92 29,520
2012-12-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 17,000 5.93 100,861
2012-12-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.61 54,150
2012-12-10 Gregory Philip D (Vice President, Research & CSO) Sale 24,000 5.46 131,040
2012-12-03 Larson John William (Director) Sale 15,000 5.62 84,300
2012-11-27 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 5.60 84,000
2012-11-27 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.61 54,150
2012-11-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 4,736 5.33 25,233
2012-11-01 Larson John William (Director) Sale 15,000 5.52 82,770
2012-10-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 20,000 5.71 114,100
2012-10-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.61 54,150
2012-10-17 Gregory Philip D (VP, Therapeutic Dev. & CMO) Sale 6,000 6.00 36,000
2012-10-17 Gregory Philip D (VP, Therapeutic Dev. & CMO) Option Ex 6,000 4.92 29,520
2012-10-15 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 5,000 5.68 28,400
2012-10-01 Larson John William (Director) Sale 15,000 6.19 92,865
2012-09-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 5.60 84,000
2012-09-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.61 54,150
2012-09-04 Larson John William (Director) Sale 15,000 5.28 79,155
2012-08-27 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 5,000 5.19 25,970
2012-08-01 Larson John William (Director) Sale 15,000 5.24 78,570
2012-07-27 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 5.60 84,000
2012-07-27 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.61 54,150
2012-07-26 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 5,000 5.05 25,259
2012-07-02 Larson John William (Director) Sale 15,000 5.24 78,525
2012-06-15 Larson John William (Director) Sale 15,000 5.00 75,000
2012-01-28 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 9.68 145,155
2012-01-28 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.61 54,150
2011-09-09 Gregory Philip D (CSO & Vice President, Research) Sale 2,500 6.00 15,000
2011-09-09 Gregory Philip D (CSO & Vice President, Research) Option Ex 2,500 3.00 7,500
2011-07-07 Ichikawa David G (Senior VP, Bus. Dev.) Sale 4,000 6.47 25,880
2011-07-07 Ichikawa David G (Senior VP, Bus. Dev.) Option Ex 4,000 5.19 20,760
2011-07-01 Gregory Philip D (CSO & Vice President, Research) Sale 15,000 6.00 90,000
2011-07-01 Gregory Philip D (CSO & Vice President, Research) Option Ex 15,000 3.45 51,750
2011-06-06 Ichikawa David G (Senior VP, Bus. Dev.) Sale 4,000 6.52 26,080
2011-06-06 Ichikawa David G (Senior VP, Bus. Dev.) Option Ex 4,000 5.19 20,760
2011-06-01 Gregory Philip D (CSO & Vice President, Research) Sale 15,000 6.81 102,150
2011-06-01 Gregory Philip D (CSO & Vice President, Research) Option Ex 15,000 3.45 51,750
2011-05-05 Ichikawa David G (Senior VP, Bus. Dev.) Sale 4,000 6.74 26,960
2011-05-05 Ichikawa David G (Senior VP, Bus. Dev.) Option Ex 4,000 5.19 20,760
2011-05-02 Gregory Philip D (CSO & Vice President, Research) Sale 15,000 7.32 109,845
2011-05-02 Gregory Philip D (CSO & Vice President, Research) Option Ex 15,000 3.45 51,750
2011-04-25 Gregory Philip D (CSO & Vice President, Research) Sale 19,433 7.54 146,563
2011-04-25 Gregory Philip D (CSO & Vice President, Research) Option Ex 15,000 3.23 48,375
2011-04-21 Ichikawa David G (Senior VP, Bus. Dev.) Sale 8,000 7.69 61,504
2011-04-21 Ichikawa David G (Senior VP, Bus. Dev.) Option Ex 8,000 5.19 41,520
2011-03-01 Gregory Philip D (CSO & Vice President, Research) Sale 2,500 8.29 20,715
2011-02-28 Cleveland Paul B (Director) Sale 1,388 9.00 12,492
2011-02-28 Cleveland Paul B (Director) Option Ex 1,388 2.04 2,831
2011-02-28 Gregory Philip D (CSO & Vice President, Research) Sale 2,500 9.00 22,500
2011-02-01 Gregory Philip D (CSO & Vice President, Research) Sale 2,500 7.97 19,925
2011-01-03 Gregory Philip D (CSO & Vice President, Research) Sale 2,500 6.80 17,000
2010-12-22 Cleveland Paul B (Director) Sale 32,037 7.00 224,259
2010-12-22 Cleveland Paul B (Director) Option Ex 32,037 3.07 98,353
2010-12-20 Cleveland Paul B (Director) Sale 11,297 7.00 79,079
2010-12-20 Cleveland Paul B (Director) Option Ex 11,297 2.04 23,045
2010-12-08 Gregory Philip D (CSO & Vice President, Research) Sale 2,500 6.00 15,000
2010-08-30 Wolff Henry Ward (Exec VP & CFO) Buy 9,000 3.00 27,000
2010-08-30 Lanphier Edward O Ii (President & CEO) Buy 10,000 3.00 30,050
2010-05-03 Gregory Philip D (CSO & Vice President, Research) Sale 2,500 6.25 15,625
2010-04-14 Gregory Philip D (CSO & Vice President, Research) Sale 2,500 6.14 15,357
2008-09-02 Gregory Philip D (Vice President, Research) Sale 1,000 10.12 10,120
2008-09-02 Gregory Philip D (Vice President, Research) Option Ex 1,000 3.00 3,000
2008-08-15 Gregory Philip D (Vice President, Research) Sale 10,000 10.67 106,679
2008-08-15 Lanphier Edward O Ii (Pres & Chief Ex Officer) Sale 25,000 10.62 265,525
2008-08-01 Gregory Philip D (Vice President, Research) Sale 1,000 10.82 10,825
2008-07-31 Larson John William (Director) Sale 5,700 11.02 62,814
2008-07-30 Larson John William (Director) Sale 3,500 11.04 38,640
2008-07-29 Larson John William (Director) Sale 19,000 11.23 213,313
2008-07-15 Lanphier Edward O Ii (Pres & Chief Ex Officer) Sale 25,000 10.25 256,150
2008-07-01 Gregory Philip D (Vice President, Research) Sale 1,000 10.01 10,005
2008-07-01 Gregory Philip D (Vice President, Research) Option Ex 1,000 4.92 4,920
2008-06-30 Lanphier Edward O Ii (Pres & Chief Ex Officer) Sale 25,000 10.21 255,324
2008-05-20 Ichikawa David G (Senior VP, Bus. Dev.) Sale 15,000 13.39 200,835
2008-05-20 Ichikawa David G (Senior VP, Bus. Dev.) Option Ex 15,000 5.19 77,850
2008-05-15 Lanphier Edward O Ii (Pres & Chief Ex Officer) Sale 25,000 13.38 334,425
2008-05-01 Gregory Philip D (Vice President, Research) Sale 1,000 12.69 12,690
2008-05-01 Gregory Philip D (Vice President, Research) Option Ex 1,000 4.92 4,920
2008-04-15 Lanphier Edward O Ii (Pres & Chief Ex Officer) Sale 25,000 11.53 286,046
2008-04-01 Gregory Philip D (Vice President, Research) Sale 1,000 10.20 10,196
2008-04-01 Gregory Philip D (Vice President, Research) Option Ex 1,000 4.92 4,920
2008-03-19 Gregory Philip D (Vice President, Research) Sale 1,000 10.01 10,010
2008-03-19 Gregory Philip D (Vice President, Research) Option Ex 1,000 4.92 4,920
2008-03-17 Lanphier Edward O Ii (Pres & Chief Ex Officer) Sale 25,000 8.79 217,739
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of SGMO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sangamo Biosciences Inc (symbol SGMO, CIK number 1001233) see the Securities and Exchange Commission (SEC) website.